A comprehensive scientific overview of Retatrutide (LY3437943), detailing its novel triple-receptor agonist mechanism across GLP-1, GIP, and GCGR, Phase 2
Retatrutide (LY3437943): Mechanisms, Evidence, and Research Potential of the GIP/GLP-1/Glucagon Tri-Agonist